S

Sarepta Therapeutics
D

SRPT

11.910
USD
-0.97
(-7.53%)
مغلق
حجم التداول
486,058
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
1,170,479,451
أصول ذات صلة
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BIIB
BIIB
-1.010
(-0.76%)
131.630 USD
BMRN
BMRN
-0.765
(-1.28%)
59.010 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
INCY
INCY
-0.300
(-0.43%)
70.180 USD
I
IONS
0.100
(0.24%)
42.240 USD
R
RCKT
-0.07500
(-2.33%)
3.14000 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
VRTX
VRTX
-2.89
(-0.61%)
469.58 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.